Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:42 am Unchanged | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | BCLS II Equity Opportunities, LP | 96,334 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:14 pm Sale | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Mgmt, L.P. | 153,861 7.840% | -9,564![]() (-5.85%) | Filing History |
| 2022-02-09 10:04 am Sale | 2022-02-08 | 13G | XILIO THERAPEUTICS INC XLO | FMR LLC | 183,591 9.357% | -6,243![]() (-3.29%) | Filing History |
| 2022-01-14 06:07 am Purchase | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | TAKEDA PHARMACEUTICAL CO LTD TAK | 105,366 5.370% | 105,366![]() (New Position) | Filing History |

